Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients

Clinical trial NCT05914857 · UNKNOWN

Trial details

NCT number: NCT05914857
Sponsor: Yangjin
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prediabetic State Impaired Fasting Glucose Impaired Glucose Tolerance

Start date: 2023-12-20
Primary completion: 2025-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.